|Articles|December 5, 2011
InterHealth Zychrome Beats Chromium in Insulin Management Study
Zychrome was deemed 1.4-fold and 2.0-fold more effective than chromium picolinate in controlling insulin levels and insulin functions respectively, according to the company.
Advertisement
InterHealth Nutraceuticals Inc. (Benicia, CA) reports that its patent-pending Zychrome brand chromium proved significantly more effective than standard chromium picolinate in a three-month clinical trial. Zychrome was deemed 1.4-fold and 2.0-fold more effective than chromium picolinate in controlling insulin levels and insulin functions respectively, according to the company.
InterHealth’s research was presented at the 52nd American College of Nutrition Meeting held November 16–19.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Artemis International: 30 Years of Science-Backed Berry and Botanical Innovation
2
Certifications, Clinical Trials, and Consumer Trust: How SGS NutriSource Serves the Industry
3
Pycnogenol supplementation effective for lipedema symptom reduction, new clinical trial demonstrates
4
New LOAM prebiotic fiber formula includes NutriLeads’ Benicaros ingredient
5
